Zimmer Biomet Holdings (ZBH) Price to Sales (2009 - 2026)

Zimmer Biomet Holdings has reported Price to Sales for 18 years, with the latest figure at 7.54 in Q2 2026.

• On a quarterly basis, Price to Sales fell 13.28% year-over-year to 7.54 in Q2 2026; TTM through Jun 2026 was 1.93, a 16.33% decrease from a year earlier, with the FY2025 full-year figure at 2.14, down 21.95% from the prior year.
• Price to Sales was 7.54 for Q2 2026 at Zimmer Biomet Holdings, down from 8.38 in the prior quarter.
• The five-year high for Price to Sales was 16.27 in Q2 2023, with the low at 7.54 in Q2 2026.
• Average Price to Sales over 5 years is 11.96, with a median of 12.08 recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Price to Sales sank 33.1% in 2022, then surged 31.54% in 2023.
• Over 5 years, Price to Sales stood at 14.6 in 2022, then declined by 11.88% to 12.86 in 2023, then declined by 19.21% to 10.39 in 2024, then slipped by 24.56% to 7.84 in 2025, then retreated by 3.8% to 7.54 in 2026.
• The last three Price to Sales figures came in at 7.54 (Q2 2026), 8.38 (Q1 2026), and 7.84 (Q4 2025), per Business Quant data.